ScanSource (SCSC) Following Director Retirement Has Its Valuation Back In Focus
ScanSource (SCSC) is back on investors’ radar after the company announced the retirement of long serving director Peter C. Browning, which coincided with a 3.7% drop in the stock.
See our latest analysis for ScanSource.
The recent 3.7% intraday drop came on top of a 5.2% decline in ScanSource’s 30 day share price return, although the 90 day share price return of 20.45% and 1 year total shareholder return of 20.90% still point to positive momentum overall.
If this kind of governance news has you thinking about where else to put fresh capital to work, it could be a good moment to check out 21 top founder-led companies
ScanSource now trades at a discount to both analyst targets and estimated fair value after this governance driven pullback. Is the market correctly pricing extra caution, or has the recent drop pushed the stock too far below fundamentals?
Most Popular Narrative: 27.6% Undervalued
The most followed narrative on ScanSource values the stock at $71 per share, well above the last close of $51.42. This frames the recent pullback as a valuation gap rather than a change in the long term story.
The accelerating enterprise shift toward digital transformation, converged IT solutions, and edge computing is driving sustained demand for integrated hardware, software, and services, allowing ScanSource to capture outsized wallet share and potentially elevate long-term revenue growth well above industry averages.
Want to see what powers that $71 fair value for ScanSource? The narrative leans on gradual revenue gains, firming margins and a future earnings multiple below many peers. Curious which specific forecasts make that math work so cleanly?
Result: Fair Value of $71 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, you still need to weigh real threats to the ScanSource story, including potential hardware commoditisation and vendors pushing more direct channels that could squeeze margins.
Find out about the key risks to this ScanSource narrative.
Next Steps
Overall sentiment around ScanSource is cautious but constructive, so it makes sense to review the underlying data quickly and decide where you stand. To see what investors are optimistic about right now, take a closer look at the 4 key rewards
Looking for more ScanSource style investment ideas?
If you are reassessing ScanSource and want fresh ideas, it can be smart to compare it with a few focused stock lists built from consistent data.
- Target companies with strong fundamentals and less fragile balance sheets by screening through the solid balance sheet and fundamentals stocks screener (50 results)
- Hunt for mispriced opportunities that combine quality and value using the screener containing 20 high quality undiscovered gems
- Prioritise resilience and potentially smoother portfolio swings by checking companies in the 78 resilient stocks with low risk scores
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com